Literature DB >> 14722297

Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.

Christoph A Kahl1, Jon Marsh, Joanne Fyffe, David A Sanders, Kenneth Cornetta.   

Abstract

Ross River virus (RRV) and Semliki Forest virus (SFV) are two alphaviruses that have a high degree of amino acid homology, as well as a very broad host range. We show here that envelope glycoproteins derived from both viruses can pseudotype human immunodeficiency virus type 1 (HIV-1)-derived lentivirus vectors. Both RRV and SFV glycoproteins considerably expand the host range of the lentivirus vector, and vectors can be efficiently concentrated by ultracentrifugation. A systematic analysis comparing the alphaviral glycoproteins to the vesicular stomatitis virus glycoprotein (VSV-G) revealed that lentivirus vectors incorporate RRV glycoproteins with an efficiency comparable to that of VSV-G. Both pseudotypes have comparable physical titers, but infectious titers with the RRV pseudotype are lower than with VSV-G. Incorporation of SFV glycoproteins into lentivirus vector is less efficient, leading to decreased physical and infectious titers. The transduction rates with VSV-G-, RRV-, and SFV-pseudotyped lentivirus vectors into adherent cell lines can be significantly increased by using a combination of Polybrene and plates coated with CH-296 recombinant fibronectin fragments. Together, our data suggest that RRV and SFV glycoproteins might be suitable as alternatives to VSV-G for pseudotyping lentivirus vectors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722297      PMCID: PMC321387          DOI: 10.1128/jvi.78.3.1421-1430.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

2.  Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency.

Authors:  J H Slingsby; D Baban; J Sutton; M Esapa; T Price; S M Kingsman; A J Kingsman; A Slade
Journal:  Hum Gene Ther       Date:  2000-07-01       Impact factor: 5.695

3.  Electrostatic interactions in the early events of VSV infection.

Authors:  C Conti; P Mastromarino; A Riccioli; N Orsi
Journal:  Res Virol       Date:  1991 Jan-Feb

4.  Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy.

Authors:  K Cornetta; W F Anderson
Journal:  J Virol Methods       Date:  1989-02       Impact factor: 2.014

5.  Species-specific, postentry barriers to primate immunodeficiency virus infection.

Authors:  W Hofmann; D Schubert; J LaBonte; L Munson; S Gibson; J Scammell; P Ferrigno; J Sodroski
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

Authors:  D L Haas; S S Case; G M Crooks; D B Kohn
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

7.  Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

Authors:  E Costello; M Munoz; E Buetti; P R Meylan; H Diggelmann; M Thali
Journal:  Gene Ther       Date:  2000-04       Impact factor: 5.250

8.  Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.

Authors:  N Emi; T Friedmann; J K Yee
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.

Authors:  Yubin Kang; Colleen S Stein; Jason A Heth; Patrick L Sinn; Andrea K Penisten; Patrick D Staber; Kenneth L Ratliff; Hong Shen; Carrie K Barker; Inês Martins; C Matthew Sharkey; David Avram Sanders; Paul B McCray; Beverly L Davidson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  19 in total

Review 1.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

2.  Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins.

Authors:  Andrey A Kolokoltsov; Scott C Weaver; Robert A Davey
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Efficient large volume lentiviral vector production using flow electroporation.

Authors:  Scott R Witting; Lin-Hong Li; Aparna Jasti; Cornell Allen; Kenneth Cornetta; James Brady; Rama Shivakumar; Madhusudan V Peshwa
Journal:  Hum Gene Ther       Date:  2011-10-24       Impact factor: 5.695

4.  Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells.

Authors:  Blair L Strang; Yasuhiro Takeuchi; Thomas Relander; Johan Richter; Ranbir Bailey; David A Sanders; Mary K L Collins; Yasuhiro Ikeda
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells.

Authors:  Steven Froelich; April Tai; Katie Kennedy; Adnan Zubair; Pin Wang
Journal:  Hum Gene Ther       Date:  2011-06-13       Impact factor: 5.695

6.  Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Authors:  Katharina M Uhlig; Stefan Schülke; Vivian A M Scheuplein; Anna H Malczyk; Johannes Reusch; Stefanie Kugelmann; Anke Muth; Vivian Koch; Stefan Hutzler; Bianca S Bodmer; Axel Schambach; Christian J Buchholz; Zoe Waibler; Stephan Scheurer; Michael D Mühlebach
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

Review 7.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

8.  Efficient and stable gene expression into human osteoclasts using an HIV-1-based lentiviral vector.

Authors:  Kang Chu; Kenneth G Cornetta; Michael J Econs
Journal:  DNA Cell Biol       Date:  2008-06       Impact factor: 3.311

9.  Functional pseudotyping of human immunodeficiency virus type 1 vectors by Western equine encephalitis virus envelope glycoprotein.

Authors:  Ananthalakshmi Poluri; Rebecca Ainsworth; Scott C Weaver; Richard E Sutton
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Venezuelan equine encephalitis virus infection of mosquito cells requires acidification as well as mosquito homologs of the endocytic proteins Rab5 and Rab7.

Authors:  Tonya M Colpitts; Andrew C Moore; Andrey A Kolokoltsov; Robert A Davey
Journal:  Virology       Date:  2007-08-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.